Abstract:Background: Oligomeric amyloid-beta peptide (A beta) is associated with dysfunctional neuronal networks and neuronal loss in the development of Alzheimer's disease (AD). Ischemic postconditioning protects against post-ischemic excitotoxicity, oxidative stress, and inflammatory process that have also been implicated in the pathogenesis of AD. Evaluating the roles of ischemic postconditioning in oligomeric A beta-induced neurotoxicity and underlying signal events may provide potential strategy for medical therapy in AD. Objectives: The aim of the present study was to explore whether and how a brief ischemic postconditioning protects against A beta neurotoxicity in rat hippocampus. Methods: Oligomeric A beta(25-35) (20 nmol/rat) or A beta(1-4)(2 )(5 nmol/rat) was infused by intracerebroventricular injection in adult male Sprague-Dawley rats. Ischemic postconditioning, a brief episode of global brain ischemia (3 min), was conducted at 1, 3, or 7 days after A beta treatment, respectively. Results: A brief ischemic postconditioning reduced neuronal loss and inhibited the activation of MLK3, MKK3/6, and P38MAPKs in rat hippocampal CA1 and CA3 subfields after A beta oligomer infusion. An N-methyl-D-aspartate (NMDA) receptor antagonist amantadine, but not non-NMDA receptor antagonist CNQX, reversed the MLK3-MKK3/6-P38MAPK signal events and beneficial effect of ischemic postconditioning on neuronal survival. Such reversion was also realized by NVP-AAM077, a GluN2A-subunit-selective NMDA receptor antagonist. Moreover, posttreatment with low doses of NMDA (5 nmol-40 nmol/rat) suppressed the A beta-induced P38MAPK signaling and imitated the neuroprotection of ischemic postconditioning against A beta neurotoxicity. Conclusions: Ischemic postconditioning provides neuroprotection against A beta neurotoxicity by moderate upregulation of NMDA receptor signaling, especially GluN2A-containing NMDA receptor pathway, and thereafter downregulation of MLK3-MKK3/6-P38MAPK signal events.

The newly identified K + channel blocker talatisamine attenuates beta-amyloid oligomers induced neurotoxicity in cultured cortical neurons

Discovery of Talatisamine As a Novel Specific Blocker for the Delayed Rectifier K+ Channels in Rat Hippocampal Neurons

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling

Role of potassium channels in Aβ1–40-activated apoptotic pathway in cultured cortical neurons

L-type calcium channel blockers rescue beta-amyloid-42–induced neurotoxicity by inhibiting CREB and CDK5 activation

P1–115: L‐type Calcium Channel Blockers Rescue Beta‐amyloid‐42–induced Neurotoxicity by Inhibiting CREB and CDK5 Activation

Tl-2 Attenuates Beta-Amyloid Induced Neuronal Apoptosis Through The Akt/Gsk-3 Beta/Beta-Catenin Pathway

The Protective Effects of Tanshinone IIA on Neurotoxicity Induced by Β-Amyloid Protein Through Calpain and the P35/cdk5 Pathway in Primary Cortical Neurons.

Protective effects of galantamine against Abeta-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress.

The Protective Effects of TanIIA on Neurotoxicity Induced by Β-Amyloid Protein Through the Cdk5/P35 Pathway in Cultured Primary Neurons

Electrophysiological characterization of 14-benzoyltalatisamine, a selective blocker of the delayed rectifier K+ channel found in virtual screening.

The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.

Tanshinone IIA Attenuates Aβ25–35‐induced Spatial Memory Impairment Via Upregulating Receptors for Activated C Kinase1 and Inhibiting Autophagy in Hippocampus

The Protective Effects of Jatrorrhizine on Β-Amyloid (25-35)-induced Neurotoxicity in Rat Cortical Neurons.

The neuroprotective effects of tanshinone IIA on β-amyloid-induced toxicity in rat cortical neurons.

A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.

Catalpol Attenuates the Neurotoxicity Induced by Β-Amyloid1–42 in Cortical Neuron–glia Cultures

The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation.

Trilobatin Protects Against Aβ25–35-Induced Hippocampal HT22 Cells Apoptosis Through Mediating ROS/p38/Caspase 3-Dependent Pathway

Different Protection of K252a and N‐acetyl‐L‐cysteine Against Amyloid‐β Peptide–induced Cortical Neuron Apoptosis Involving Inhibition of MLK3–MKK7–JNK3 Signal Cascades

Tetrahydroxy stilbene glycoside (TSG) antagonizes Aβ-induced hippocampal neuron injury by suppressing mitochondrial dysfunction via Nrf2-dependent HO-1 pathway.